FDA AIDS Announcements, First Quarter 2005

Summary:

Here are the eight announcements from the AIDS list serve of the U.S. Food and Drug Administration, from January through March 2005.

The U.S. Food and Drug Administration distributed eight announcements on its AIDS list serve in January, February, and March 2005. Each one will be important for some of our readers. You can obtain all of these and any later announcements at the FDA HIV/AIDS List Serve Archive page, www.fda.gov/oashi/aids/listserve/archive.html.

The eight announcements starting with the most recent are:

• Important information about Sustiva (efavirenz) and pregnancy, 2005-03-31
• Notice of important new drug interactions (Norvir or Kaletra), 2005-03-30
• Approval of Baraclude (entecavir) for treatment of chronic hepatitis B virus infection, 2005-03-30
• Updated guidelines for the use of antiretroviral agents in pediatric HIV infection, 2005-03-24
• Pegasus and Copegus indications expanded to include treatment of hepatitis C and HIV coinfection, 2005-03-02
• Drug interaction warning: Saquinavir/ritonavir and rifampin, 2005-02-08
• FDA warning -- unapproved home-use diagnostic test kits, 2005-02-07
• Tentative approval of copackaged antiretroviral for PEPFAR availability, 2005-01-26

You can also use the Archive page to subscribe to the FDA's AIDS list serve, if you want to be notified by email of future announcements when they go out.

ISSN # 1052-4207

Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.